The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Do weight loss claims = disease claims?

    In April, GlaxoSmithKline filed a citizen’s petition with the FDA asking the agency to treat weight loss claims for dietary supplements as disease claims.

    This doesn’t sit well with the supplements industry, but is the right thing to do?

    An article at The Natural Foods Merchandiser informs us “Dietary supplements are allowed to make structure/function claims regarding weight loss, but not to claim that a supplement can eliminate a disease state, such as obesity.”

    For example…

    • You can say “Product X can help get you back in shape for summer.”
    • But not, “Product X can help you lose 80 pounds in a few months.”

    Glaxo, supported by the American Dietetic Association, says consumers believe that any kind of weight loss claim for a dietary supplement is an obesity claim. Therefore, dietary supplements makers are really marketing drugs, and their products shouldn’t be allowed on the market.

    The bottom line?
    Obviously, Glaxo is defending its over-the-counter diet pill, Alli — a low-dose version of Xenical.

    But before you snicker, go here. Scroll down below the table and then tell me if Glaxo’s position has merit

    Who supports that website? It’s difficult to tell, but the ad on the left is not a Google ad, Amazon ad, or a Blogad.

    5/7/08 19:20 JR

    Leave a Comment

    You must be logged in to post a comment.